VICKI COOK: Open Payments
NPI 1548820384 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 9 payments from 5 companies in 2025. Trend: 2023 $319 · 2024 $419 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $205 |
| Madrigal Pharmaceuticals | 2 | $91 |
| GENZYME CORPORATION | 1 | $81 |
| Gilead Sciences, Inc. | 2 | $49 |
| Lilly USA, LLC | 1 | $26 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, OMVOH.
Industry payments across ME — which companies pay providers there.
